Clarius Group LLC’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Sell |
19,138
-820
| -4% | -$7.25K | 0.01% | 461 |
|
|
2025
Q1 | $215K | Hold |
19,958
| – | – | 0.01% | 446 |
|
|
2024
Q4 | $255K | Hold |
19,958
| – | – | 0.02% | 356 |
|
|
2024
Q3 | $551K | Hold |
19,958
| – | – | 0.04% | 204 |
|
|
2024
Q2 | $579K | Hold |
19,958
| – | – | 0.04% | 194 |
|
|
2024
Q1 | $890K | Hold |
19,958
| – | – | 0.06% | 135 |
|
|
2023
Q4 | $774K | Hold |
19,958
| – | – | 0.06% | 162 |
|
|
2023
Q3 | $587K | Hold |
19,958
| – | – | 0.06% | 194 |
|
|
2023
Q2 | $1.27M | Buy |
19,958
+19,138
| +2,334% | +$1.22M | 0.1% | 112 |
|
|
2023
Q1 | $38.7K | Hold |
820
| – | – | ﹤0.01% | 504 |
|
|
2022
Q4 | $57K | Hold |
820
| – | – | 0.01% | 504 |
|
|
2022
Q3 | $120K | Hold |
820
| – | – | 0.01% | 472 |
|
|
2022
Q2 | $107K | Hold |
820
| – | – | 0.01% | 456 |
|
|
2022
Q1 | $127K | Hold |
820
| – | – | 0.01% | 484 |
|
|
2021
Q4 | $127K | Buy |
+820
| New | +$127K | 0.01% | 484 |
|